Glenmark Pharmaceuticals informed the exchanges on Wednesday that it has been granted final approval by United States Food & Drug Administration (USFDA) for Dimethyl Fumarate delayed-release capsules, 120 mg and 240 mg, the generic version of Tecfidera delayed-release capsules, 120 mg and 240 mg, of Biogen, Inc.

The shares of Thyrocare Technologies have gained by almost 31.45 per cent in just two trading sessions. The stock has been buzzing since the second day of this week when it jumped by 14.10 per cent during Tuesday’s trading session.

This is the fifth investment in RRVL after other leading global investors namely Silver Lake, KKR, General Atlantic, Mubadala, GIC & TPG invested a total of Rs 37,710 crore in less than four weeks.

Blue Star Limited on Wednesday announced the launch of a wide range of new products & solutions with virus deactivation technology (VDT). Post this development, the stock of Blue Star witnessed a jump of more than 4 per cent today. 

It concluded by saying that strong demand for the services, Indian rupee depreciation, and cost-control measures, such as salary freezes during downturns, support stable profitability.

Franklin Templeton has become a talk of the town lately; initially for its closure of six debt schemes but now, a case of misconduct by its key management personnel is stealing headlines. Read on to find out more.

The company witnessed substantial growth in pre-sales for Q2FY21 at Rs 200 crore, up by 98 per cent on a QoQ basis and up by 96 per cent on a YoY basis.

The early trends from SGX Nifty indicate that bulls are in no mood to halt their northward express as SGX Nifty is indicating Nifty to open up by 26 points at the 11,701 mark.

As the price structure and indicator set-up are clearly suggesting a positive bias, we would advise the traders to continue with long positions and look for booking profit around the level of 11,750-11,794. Stocks in news: Sunteck Realty, Reliance Industries, Tata Motors, Bajaj Finance, IEX.

Recently, SEBI made an effort to make multi-cap funds ‘true to its label’. And now, it is making riskometer follow the same. Read on to find out more.